A previous study already demonstrated that IL-4 expression was also downregulated in patients with asthma and COPD overlap (ACO), proposing IL-4 as a biomarker to distinguish between asthma and ACO. The gene discussed is IL4; the disease is chronic obstructive pulmonary disease.